日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dynamics of BCR::ABL1 transcript levels and clinical outcomes after switch to second-line therapy in pediatric chronic myeloid leukemia

儿童慢性粒细胞白血病二线治疗后BCR::ABL1转录水平的动态变化及临床结局

Sembill, Stephanie; Zerjatke, Thomas; Winterstein, Micha; Ghete, Tabita; Schirmer, Elke; Wotschofsky, Zofia; Suttorp, Meinolf; Krumbholz, Manuela; Karow, Axel; Glauche, Ingmar; Metzler, Markus

Sequential BCR::ABL1 evaluation during dose de-escalation in peripheral blood is more predictive of TFR success than single assessment at dose de-escalation in either peripheral blood or bone marrow

在剂量递减期间,对外周血进行连续的 BCR::ABL1 评估比在剂量递减时对外周血或骨髓进行单次评估更能预测无治疗反应 (TFR) 的成功率。

Patterson, S D; Gottschalk, A; Hayden, C; Young, R; Hair, A; Jørgensen, H G; Wheadon, H W; Apperley, J F; Glauche, I; Clark, R E; Copland, M; Roeder, I

Erratum for the Research Article "TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by recruiting ABL1" by M. Hossain et al

M. Hossain 等人的研究论文“TIE2 介导的 H4 酪氨酸磷酸化通过募集 ABL1 来调节 DNA 损伤反应”的勘误

BCR-ABL1 Drives Transcriptional Reprogramming of Chronic Myeloid Leukemia Cells for Immune Evasion Through C/EBPβ

BCR-ABL1通过C/EBPβ驱动慢性粒细胞白血病细胞的转录重编程以实现免疫逃逸

Lu, Xiaocui; Fang, Hui; Liu, Yuan; Liu, Chang; Fang, Xuexiu; Matsunaga, Atsuko; Mori, Stephanie F; Zhang, Ting; Wang, Gavin; Zhou, George I; Yu, Miao; Ding, Haocheng; Cortes, Jorge; Cheng, Bo; Hu, Tianxiang

Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer

靶向 ANGPTL4/NRP1/ABL1/RAD51 轴可通过损害头颈癌中的 DNA 损伤修复来逆转顺铂耐药性。

Asiedu, Emmanuel B; Kumar, Ajay; Choi, Alexander; Luciano, Derek Osorio; Lo, Kevin; Sharma, Deepti; Ma, Tao; Rassool, Feyruz; Sodhi, Akrit; Montaner, Silvia

Primary asciminib resistance in a chronic myeloid leukemia patient with the atypical BCR::ABL1 e13a3 transcript: a case study

一例伴有非典型 BCR::ABL1 e13a3 转录本的慢性粒细胞白血病患者出现原发性 asciminib 耐药:病例研究

Jung, Birte Kristin; Weißmann, Sandra; Schock, Caroline; Meggendorfer, Manja; Haferlach, Torsten; Dicker, Frank

Nbeal2 Inactivation Triggers Abl1 Stabilisation and Dysregulated Subcellular Localisation of the Multi-Drug-Resistant Protein MDR1 (ABCB1) in Mast Cells.

Nbeal2 失活触发肥大细胞中 Abl1 稳定和多药耐药蛋白 MDR1 (ABCB1) 的亚细胞定位失调。

Correction: Danzero et al. An Automated Cartridge-Based Microfluidic System for Real-Time Quantification of BCR::ABL1 Transcripts in Chronic Myeloid Leukemia: An Italian Experience. Int. J. Mol. Sci. 2025, 26, 8932

更正:Danzero 等人,《用于实时定量慢性粒细胞白血病中 BCR::ABL1 转录本的自动化基于卡盒的微流控系统:意大利经验》,《国际分子科学杂志》,2025 年,26,8932。

Danzero, Alice Costanza; Gottardi, Enrico Marco; Quarantelli, Fabrizio; Del Prete, Ciro; Potenza, Alessandra; Venturi, Claudia; Berchialla, Paola; Guerrini, Francesca; Bono, Clara; Ottaviani, Emanuela; Galimberti, Sara; Fava, Carmen; Izzo, Barbara

Targeting leukemic stem and progenitor cells expressing different BCR::ABL1 levels: antileukemic activity of asciminib with or without TKIs

靶向表达不同 BCR::ABL1 水平的白血病干细胞和祖细胞:asciminib 联合或不联合 TKI 的抗白血病活性

Massimino, Michele; Tirrò, Elena; Romano, Chiara; Stella, Stefania; Tomarchio, Cristina; Vitale, Silvia Rita; Manzella, Livia; Di Raimondo, Francesco; Stagno, Fabio; Vigneri, Paolo

Therapeutic Targets for Overcoming BCR::ABL1 Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia

克服慢性粒细胞白血病中 BCR::ABL1 酪氨酸激酶抑制剂耐药性的治疗靶点

Tsubaki, Masanobu; Matsuo, Taira; Komori, Rie